Rai Sujeet, Verma Satyajeet, Yadav Pramod Kumar, Ahmad Jawed, Yadav Harikesh Kumar
Department of Anaesthesiology, MRA Medical College, Ambedkar Nagar, Uttar Pradesh, India.
Department of Surgery, MRA Medical College, Ambedkar Nagar, Uttar Pradesh, India.
Anesth Essays Res. 2017 Oct-Dec;11(4):909-912. doi: 10.4103/aer.AER_86_17.
Easy availability of autologous blood is difficult in rural areas. Acute normovolemic hemodilution (ANH) has been found to be an effective alternative in major surgeries where we are expecting major blood loss.
A prospective comparative study was designed to evaluate the utility of ANH patients (patients receiving autologous blood) during major operations done at MRA Medical College Ambedkar Nagar, Uttar Pradesh, India. during from September 2015 to September 2016. A total of 60 patients undergoing major surgeries were randomly assigned into two groups of thirty patients' each. Group I received homologous blood intraoperative only when required. In Group II ANH was initiated to a target hematocrit of 30% after induction of anesthesia. Various parameters such as demographic, biochemical, and hemodynamic were compared.
The mean value of blood withdrawn in ANH group was 650.5 ± 228 ml and it was replaced with an equal volume of 6% hydroethyl starch. There was no statistically significant variation in mean hemocrits levels in both the groups at various stages of the study. Hematocrits decreased significantly in both the groups at various stages as compared to preoperative values. The heart rate and mean blood pressure were almost similar and without statistically significant differences in both groups. Surgical blood loss in Group I was 895.29 ± 568.30 ml as compared to 765 ± 506 ml in Group II. The difference was statistically insignificant ( ≥ 0.05). The mean volume of homologous blood transfused in Group I was 850.71 ± 318.29 ml, as compared to nil in Group II which was statistically significant ( < 0.05).
It concludes that ANH up to a target hematocrit of 30% is safe and effective in reducing the need for homologous blood in various major surgeries in institutes in rural areas.
在农村地区,自体血的便利获取较为困难。急性等容血液稀释(ANH)已被证明是在预计会有大量失血的大型手术中的一种有效替代方法。
设计了一项前瞻性比较研究,以评估在印度北方邦阿姆贝德卡尔讷格尔的MRA医学院进行的大型手术中ANH患者(接受自体血的患者)的效用。研究时间为2015年9月至2016年9月。总共60例接受大型手术的患者被随机分为两组,每组30例。第一组仅在需要时术中输注异体血。第二组在麻醉诱导后将ANH起始至目标血细胞比容为30%。比较了各种参数,如人口统计学、生化和血流动力学参数。
ANH组采集的平均血量为650.5±228毫升,并用等体积的6%羟乙基淀粉进行置换。在研究的各个阶段,两组的平均血细胞比容水平没有统计学上的显著差异。与术前值相比,两组在各个阶段的血细胞比容均显著下降。两组的心率和平均血压几乎相似,且无统计学上的显著差异。第一组的手术失血量为895.29±568.30毫升,第二组为765±506毫升。差异无统计学意义(≥0.05)。第一组输注的异体血平均量为850.71±318.29毫升,第二组为零,差异有统计学意义(<0.05)。
得出结论,在农村地区的机构中,将ANH起始至目标血细胞比容为30%在减少各种大型手术中对异体血的需求方面是安全有效的。